Amendment_0001_-_15-100-SOL-00003.pdf

This notice provides details regarding a forthcoming Request for Proposal for medical countermeasures to support pandemic influenza preparedness and response efforts. The Biomedical Advanced Research and Development Authority within the Department of Health and Human Services intends to solicit proposals for the supply of influenza vaccine master seeds, research lots, investigational lots, commercial scale bulk lots, adjuvants, formulation and filling services, storage and stability testing, shipping, candidate vaccine viruses, potency reagents and analytical testing through January 2023 with a base period of three years and two one-year options to extend. Proposers must demonstrate experience manufacturing influenza vaccines either through licensure or ongoing vaccine development including phase 3 clinical trials and a pending Biologics License Application. The anticipated release of the RFP is January 12, 2015 with proposals due February 20, 2015 and estimated contract awards in July 2015.